Methyl 4-Bromo-3-methoxythiophene-2-carboxylate
CAS : 110545-67-0
Ref. 3D-KEA54567
| 1g | Arrêté | ||
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
Methyl 4-Bromo-3-methoxythiophene-2-carboxylate
Description :
Methyl 4-bromo-3-methoxythiophene-2-carboxylate (MBMTC) is a synthetic anticancer agent that inhibits protein tyrosine phosphatases. It has shown potent inhibitory activity against PTP1B, a protein tyrosine phosphatase that plays an important role in the regulation of cell proliferation and differentiation. MBMTC has been shown to inhibit hematopoietic progenitor cells, which may be due to its ability to inhibit hematopoietic growth factor receptor and hematopoietic growth factor 1 (HGF1). MBMTC also inhibits protein synthesis by binding to ribosomes and inhibiting translation. This drug has been shown to have anticancer activity in vitro and in vivo.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
251.09 g/mol
Formule :
C7H7BrO3S
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
